Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05847673 · ClinicalTrials.gov registry record · NA
Avatar-Led Digital Therapeutic for Aiding Smoking Cessation in Sexual and Gender Minority Young Adults
A NA study, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 125
- Enrollment target
NCT05847673 is a NA study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 125 participants.
The verdict
NCT05847673, a NA study, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
Study Summary
This trial assesses the acceptability and preliminary efficacy of Empowered, Queer, Quitting, and Living (EQQUAL) smoking-cessation intervention for sexual and gender minority young adult smokers. The prevalence of tobacco use among sexual and gender minority (SGM) young adults is more than twice as high as non-SGM young adults, suggesting that existing SGM-related disparities in tobacco use will persist well into the foreseeable future unless sustained efforts are undertaken to address them. EQQUAL is an online smoking cessation intervention designed specifically for SGM young adult smokers, and may help them quit smoking.
Interventions
- OTHER Questionnaire Administration
- OTHER Health Promotion and Education
- BEHAVIORAL Online Smoking Cessation Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2023-08-20 |
| Est. Completion | 2024-06-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05847673
The ClinicalTrials.gov registry entry for NCT05847673 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT05847673 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05847673 about?
NCT05847673 is a clinical study titled "Avatar-Led Digital Therapeutic for Aiding Smoking Cessation in Sexual and Gender Minority Young Adults". This trial assesses the acceptability and preliminary efficacy of Empowered, Queer, Quitting, and Living (EQQUAL) smoking-cessation intervention for sexual and gender minority young adult smokers. The prevalence of tobacco use among sexual and gender minority (SGM) young adults is more than twice as...
What is the current status of trial NCT05847673?
This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2023-08-20. Estimated completion is 2024-06-13.
What interventions are being tested in trial NCT05847673?
The interventions under investigation include: Questionnaire Administration (OTHER), Health Promotion and Education (OTHER), Online Smoking Cessation Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05847673?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.